Cardiovascular Function of Peripheral Dopamine Receptors: Clinical Pharmacology
Editat de Paul Hiebleen Limba Engleză Hardback – 28 sep 1989
Preț: 1210.63 lei
Preț vechi: 2047.14 lei
-41% Nou
Puncte Express: 1816
Preț estimativ în valută:
231.71€ • 241.50$ • 192.89£
231.71€ • 241.50$ • 192.89£
Carte tipărită la comandă
Livrare economică 04-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780824781002
ISBN-10: 0824781007
Pagini: 384
Dimensiuni: 152 x 229 x 23 mm
Greutate: 0.68 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
Seria Clinical Pharmacology
Locul publicării:Boca Raton, United States
ISBN-10: 0824781007
Pagini: 384
Dimensiuni: 152 x 229 x 23 mm
Greutate: 0.68 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
Seria Clinical Pharmacology
Locul publicării:Boca Raton, United States
V-ar putea interesa
-
Liposome TechnologyGregoriadis Gregory-26%Preț: 1985.48 lei2668.68 lei -
The Pharmacology of Alcohol and Drugs of Abuse and AddictionNorman S. Miller-5%Preț: 699.68 lei736.50 lei -
Chemical Dependence: Diagnosis, Treatment, and PreventionH. Thomas Jr. Milhorn-5%Preț: 363.05 lei382.16 lei -
-5%Preț: 363.39 lei382.53 lei -
Pharmacokinetics: A Modern ViewLeslie Z. Benet-5%Preț: 715.66 lei753.32 lei -
Neuropharmacology and BehaviorBernard Haber-5%Preț: 354.72 lei373.39 lei -
Bio-Targets and Drug Delivery ApproachesSabyasachi Maiti-26%Preț: 990.56 lei1334.34 lei -
-26%Preț: 992.16 lei1335.29 lei -
Medicinal Plants: Culture, Utilization and PhytopharmacologyThomas S. C. Li-26%Preț: 1574.65 lei2127.35 lei -
Kinase Inhibitors: Methods and ProtocolsBernhard Kuster-5%Preț: 1071.38 lei1127.76 lei -
Pharmaceutical Dosage Forms: CapsulesLarry L. Augsburger-26%Preț: 990.56 lei1334.34 lei -
Obesity: Pathology and TherapyDean H. Lockwood-5%Preț: 707.82 lei745.07 lei -
Neurotrophic FactorsFranz Hefti-5%Preț: 697.88 lei734.61 lei -
-5%Preț: 1082.92 lei1139.91 lei -
-5%Preț: 690.25 lei726.58 lei -
Genetic and Therapeutic Aspects of Lipid and Purine MetabolismGünther Wolfram-5%Preț: 690.80 lei727.16 lei -
Ergot: The Genus ClavicepsVladimir Kren-26%Preț: 1052.69 lei1413.71 lei -
Structure-Activity Relationships of Anti-Tumour AgentsD.N. Reinhoudt-5%Preț: 358.59 lei377.45 lei -
-5%Preț: 353.97 lei372.59 lei -
-5%Preț: 360.19 lei379.14 lei -
-5%Preț: 355.07 lei373.76 lei -
-5%Preț: 355.22 lei373.92 lei -
-5%Preț: 373.35 lei392.99 lei -
-5%Preț: 378.67 lei398.60 lei -
-5%Preț: 384.90 lei405.15 lei
Public țintă
Academic and PostgraduateCuprins
Part I: Characterization of Peripheral Dopamine Receptors 1. Functional Models for and Characteristics of DA1 and DA2 Dopamine Receptors in the Periphery 2. Affinities of Dopamine Agonists and Antagonists for Peripheral Dopamine Receptors Part II: Inhibition of Sympathetic Neurotransmission by Dopaminergic Agonists 3. Effect of Rigid and Nonrigid Analogs of Dopamine on Vascular Neurotransmission 4. Inhibition of Cardiac Neurotransmission In Vivo and In Vitro by Structural Analogs of Dopamine 5. Cardiac and Vascular Consequences of Modulation of Sympathetic Neurotransmission by Dopamine Receptor Agonists Part III: Cardiovascular Effects of Selective Dopamine Receptor Agonists in Experimental Animals 6. The Pentobarbital-Anesthesized Rat: Cardiovascular Mechanisms of Action of DA1 and DA2 Receptor Agonists 7. Correlation of Dopamine Receptor Selectivity and Hemodynamic Effects on the Intact Animal 8. Peripheral Dopaminergic Agonist Activity of Aminoethylindolones and Related Compounds 9. Cardiovascular Activity of Ergoline Derivatives 10. Inhibition of Dopamine β-Hydroxylase to Increase Dopaminergic Tone In Vivo Part IV: Dopamine Receptors in Man: Therapeutic Applications 11. Clinical Utility of Cardiovascular Agents Acting on the Dopamine Receptor 12. Dopaminergic Control of Aldosterone Secretion 13. Hemodynamic Activity of N-n -propyl-N-n -Butyldopamine 14. Clinical Effects of Fenoldopam, a Potent Dopamine (DA1) Agonist
Descriere
This volume deals with the consequences of activation of peripheral dopamine receptors impacting on the cardiovascular system, either the prejunctional neuroinhibitory dopamine receptor or the postjunctional dopamine receptor. It is useful for cardiovascular clinicians and receptor specialists.